Glenmark Life Sciences Q1 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
833-0.65 (-0.08%)
Volume3.88 K
Updated: Thu 23 May, 2024 | 09:29:02
NSE
8429.75 (1.17%)
Volume422.00
Updated: Thu 23 May, 2024 | 09:07:42
Today: 831.25
858.35
52-Wk: 512.70
904.20

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Glenmark Life Sciences Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 23Mar 23QoQ Comp
    Total Revenue 2,478.232,461.120.70%
    Selling/ General/ Admin Expenses Total 168.29158.436.22%
    Depreciation/ Amortization 60.2459.032.05%
    Other Operating Expenses Total 46.4237.9922.19%
    Total Operating Expense 1,931.111,849.654.40%
    Operating Income 547.12611.47-10.52%
    Net Income Before Taxes 431.80521.24-17.16%
    Net Income 309.84389.68-20.49%
    Diluted Normalized EPS 32.0540.30-20.48%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App